<?xml version="1.0" encoding="UTF-8"?>
<ref id="CIT0026">
 <label>26</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Ding</surname>
    <given-names>Z</given-names>
   </name>, 
   <name name-style="western">
    <surname>Zhou</surname>
    <given-names>M</given-names>
   </name>, 
   <name name-style="western">
    <surname>Zeng</surname>
    <given-names>C.</given-names>
   </name>
  </person-group>
  <article-title>Recent advances in isatin hybrids as potential anticancer agents</article-title>. 
  <source>Arch Pharm (Weinheim)</source>
  <year>2020</year>;
  <volume>353</volume>:
  <fpage>e1900367</fpage>.
  <pub-id pub-id-type="pmid">31960987</pub-id>
 </mixed-citation>
</ref>
